# Mineralys Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:03584097-785e-40d5-8b99-2cabf560d6e0 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/mineralys-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 18 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:45:58.418703+00:00 | | Last reviewed | 2026-10-17T04:45:58.418703+00:00 | ## Identity - Legal name: Mineralys Therapeutics, Inc. - Display name: Mineralys Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T12:03:11.417072+00:00 | | Completeness | 0.364 | | Record Quality | 0.807 | | Directors | 7 | | Committees | 0 | | Governance events | 3 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | NOT_REVIEWED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Alexander Gold, M.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:6 - Brian Taylor Slingsby, M.D., Ph.D., M.P.H.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:7 - Daphne Karydas: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:8 - Derek DiRocco, Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:9 - Glenn P. Sblendorio: Chairman. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:5 - Jon Congleton: President and Chief Executive Officer and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:10 - Srinivas Akkaraju, M.D., Ph.D.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:11 ## Executive leadership - Anton J. Levy: Chief Financial Officer and Secretary [CFO]. Status: current. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:13 - David Rodman: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:14 - Eric Warren: Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:16 - Adam Levy: Chief Financial Officer and Secretary [CFO]. Status: unknown. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:12 - David Rodman, M.D.: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:15 - Eric Warren, R.Ph.: Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:17 - Jon Congleton: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:18 ## Governance events - CFO_CHANGED: Anton J. Levy executive of Mineralys Therapeutics, Inc., effective 2026-03-12. Effective: 2026-03-12. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:1sbruupglq9b7 - EXECUTIVE_APPOINTED: David Rodman executive of Mineralys Therapeutics, Inc., effective 2026-03-12. Effective: 2026-03-12. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:nbxx8i1hmxzby - EXECUTIVE_APPOINTED: Eric Warren executive of Mineralys Therapeutics, Inc., effective 2026-03-12. Effective: 2026-03-12. Detected: 2026-10-17T04:45:58.418703+00:00. event_id=alpha:event:transition:153ch3ny3cnfx ## Scoped resources - `alpha://company/mineralys-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record - `alpha://company/mineralys-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=identity - `alpha://company/mineralys-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/mineralys-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=board - `alpha://company/mineralys-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=committees - `alpha://company/mineralys-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=leadership - `alpha://company/mineralys-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=ownership - `alpha://company/mineralys-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=financials - `alpha://company/mineralys-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/mineralys-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=compensation - `alpha://company/mineralys-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=governance - `alpha://company/mineralys-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/mineralys-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=audit - `alpha://company/mineralys-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=legal - `alpha://company/mineralys-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=risk - `alpha://company/mineralys-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=cyber - `alpha://company/mineralys-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/mineralys-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=agents - `alpha://company/mineralys-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/mineralys-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=events - `alpha://company/mineralys-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=relationships - `alpha://company/mineralys-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=assessments - `alpha://company/mineralys-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Glenn P. Sblendorio: Chairman. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b7a26aae2d3476770fc16d63662c1bfbe5d11bc9b88d9da24864d0f64f85f251. - Alexander Gold, M.D.: Director. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b7a26aae2d3476770fc16d63662c1bfbe5d11bc9b88d9da24864d0f64f85f251. - Brian Taylor Slingsby, M.D., Ph.D., M.P.H.: Director. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b7a26aae2d3476770fc16d63662c1bfbe5d11bc9b88d9da24864d0f64f85f251. - Daphne Karydas: Director. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b7a26aae2d3476770fc16d63662c1bfbe5d11bc9b88d9da24864d0f64f85f251. - Derek DiRocco, Ph.D.: Director. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b7a26aae2d3476770fc16d63662c1bfbe5d11bc9b88d9da24864d0f64f85f251. - Jon Congleton: President and Chief Executive Officer and Director. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b7a26aae2d3476770fc16d63662c1bfbe5d11bc9b88d9da24864d0f64f85f251. - Srinivas Akkaraju, M.D., Ph.D.: Director. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b7a26aae2d3476770fc16d63662c1bfbe5d11bc9b88d9da24864d0f64f85f251. - Adam Levy: Chief Financial Officer and Secretary. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b7a26aae2d3476770fc16d63662c1bfbe5d11bc9b88d9da24864d0f64f85f251. - Anton J. Levy: Chief Financial Officer and Secretary. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:13. Valid from: 2026-03-12. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4515322d62ef6708e0b66bf26916cfd80764cd8e34cd4f058e62e0bd5bf6711e. - David Rodman: Chief Medical Officer. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:14. Valid from: 2026-03-12. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:72ad3af18579d444628cb332ca1efad30a3ad3137ff1060ed05e128a4f4afd0b. - David Rodman, M.D.: Chief Medical Officer. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b7a26aae2d3476770fc16d63662c1bfbe5d11bc9b88d9da24864d0f64f85f251. - Eric Warren: Chief Commercial Officer. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:16. Valid from: 2026-03-12. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d14d9bf9ed1859e36b504e54abfe6aad806556787308ffbeb51b60e8ee0fbc8d. - Eric Warren, R.Ph.: Chief Commercial Officer. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7c96702eb768270c9678201b7ea72a757870a3e36bafd0b4949ed9affc347222. - Jon Congleton: President and Chief Executive Officer. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b7a26aae2d3476770fc16d63662c1bfbe5d11bc9b88d9da24864d0f64f85f251. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Mineralys Therapeutics, Inc.. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:59235f324f9c5d4c45cab4641601a5ad3b2d738bebae197730172a3c575c1e4f. ## Entity Status - Public listing published. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:59235f324f9c5d4c45cab4641601a5ad3b2d738bebae197730172a3c575c1e4f. ## Published Fact - US. Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:59235f324f9c5d4c45cab4641601a5ad3b2d738bebae197730172a3c575c1e4f. ## Security Listing - MLYS (NASDAQ). Claim: alpha:claim:company:03584097-785e-40d5-8b99-2cabf560d6e0:security_listing:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:59235f324f9c5d4c45cab4641601a5ad3b2d738bebae197730172a3c575c1e4f. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:59235f324f9c5d4c45cab4641601a5ad3b2d738bebae197730172a3c575c1e4f: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/mineralys-therapeutics-inc). - alpha:projection-evidence:document:b7a26aae2d3476770fc16d63662c1bfbe5d11bc9b88d9da24864d0f64f85f251: [SEC DEF 14A 0001933414-26-000069](https://www.sec.gov/Archives/edgar/data/1933414/000193341426000069/mlys-20260408.htm). - alpha:projection-evidence:document:4515322d62ef6708e0b66bf26916cfd80764cd8e34cd4f058e62e0bd5bf6711e: [MLYS 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1933414/000193341426000056/mlys-20251231.htm). - alpha:projection-evidence:document:72ad3af18579d444628cb332ca1efad30a3ad3137ff1060ed05e128a4f4afd0b: [MLYS 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1933414/000193341426000056/mlys-20251231.htm). - alpha:projection-evidence:document:d14d9bf9ed1859e36b504e54abfe6aad806556787308ffbeb51b60e8ee0fbc8d: [MLYS 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1933414/000193341426000056/mlys-20251231.htm). - alpha:projection-evidence:document:7c96702eb768270c9678201b7ea72a757870a3e36bafd0b4949ed9affc347222: MLYS executive roster source. ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/mineralys-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/mineralys-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/mineralys-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/mineralys-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T12:03:11.039201+00:00; recorded 2026-10-17T12:03:11.039201+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.